Retatrutide Research

Retatrutide Molecular Structure and Properties

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Retatrutide is a lipidated 39-residue peptide of approximately 4,731 Da, supplied as a white lyophilised powder. Its fatty-acid chain makes it amphipathic, which affects solubility behaviour in ways an unmodified peptide of the same length would not show.

Key facts

Physical form
White lyophilised powder
Residues
39
Reported MW
~4,731 Da
Lipid
C20 diacid at Lys17
Character
Amphipathic
Class
Lipidated peptide

What lipidation does to physical behaviour

Attaching a twenty-carbon diacid to a peptide creates a molecule with a hydrophilic peptide portion and a hydrophobic tail. Amphipathic molecules behave differently from either extreme: they orient at interfaces, they can self-associate above a threshold concentration, and their solubility is more sensitive to buffer composition than an unmodified peptide's.

Why that matters at interfaces

All peptides denature at air-liquid interfaces, which is why shaking is discouraged. A lipidated peptide is more surface-active than most, because the hydrophobic tail actively drives it to the interface. Foaming is therefore more consequential here than for a highly hydrophilic short peptide such as Selank or TB-500.

Research material referenced

Retatrutide 10mg, third-party HPLC tested

Buy Retatrutide · £59.99

Composition and analysis

At 39 residues on a GIP scaffold the peptide contains aromatic residues, so absorbance near 280 nm is available for quantification. Unlike several shorter peptides in this library that lack any aromatic residue. Mass spectrometry against the stated mass is the identity check, with the caveat that the expected value itself is reported rather than database-verified.

Why a 39-mer is a demanding synthesis

Coupling efficiency compounds across every cycle. At 99% per step, thirty-eight couplings finish around 68% full-length before purification; at 98% it falls to about 46%. Add the conjugation chemistry for the lipid and linker, and retatrutide is among the more difficult syntheses in the catalogue, which is directly relevant to what a purity figure means for it.

Comparison within the incretin family

Semaglutide at 4,114 Da carries a C18 diacid; tirzepatide at 4,813 Da carries a C20; retatrutide at approximately 4,731 Da also carries a C20. All three are lipidated peptides of similar size built for the same reason, and their handling characteristics are correspondingly similar, which is more useful to know than any single figure.

Frequently asked questions

Why is retatrutide more surface-active than other peptides?

Its fatty-acid chain makes it amphipathic, actively driving it to air-liquid interfaces where peptides denature. Foaming matters more here.

Can it be quantified at 280 nm?

Yes. At 39 residues on a GIP scaffold it contains aromatic residues, unlike several shorter peptides in this library.

Is 39 residues a hard synthesis?

Yes. At 99% coupling efficiency per step, thirty-eight couplings finish around 68% full-length before purification.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More Retatrutide Research articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.